Brainstorm Cell Therapeutics Inc.

NasdaqCM:BCLI Stock Report

Market Cap: US$7.1m

Brainstorm Cell Therapeutics Inc. Company Information

Brainstorm Cell Therapeutics Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Brainstorm Cell Therapeutics Inc.
  • Ticker: BCLI
  • Exchange: NasdaqCM
  • Founded: 2000
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$7.129m
  • Shares Outstanding: 5.70m
  • Website: https://www.brainstorm-cell.com

Number of Employees

Location

  • Brainstorm Cell Therapeutics Inc.
  • 1325 Avenue of Americas
  • 28th Floor
  • New York
  • New York
  • 10019
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
BCLINasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDMay 2003
GHDDB (Deutsche Boerse AG)YesCommon StockDEEURMay 2003

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/24 16:12
End of Day Share Price 2024/11/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.